Delivery Order SPE2DB20D9329-SPE2DB23FZK04

Award Date 2/23/23
Potential Completion Date 3/16/23
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,009.65 contract is for the delivery of Kyleena 19.5 mg systems, a contraceptive product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,203.86 contract is for the delivery of 4566759551 - KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product, with a completion date of January 2, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,805.79 contract is for the supply of Kyleena 19.5 mg contraceptive systems to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery orders for a range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,203.86 contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product, to support the medical supply needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $5,868.00 contract is for the delivery of the contraceptive device KYLEENA 19.5 MG SYSTEMS to support the recurring medical supply needs of military health facilities. The contract has an ultimate completion date of October 9, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite...
This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) on December 13, 2023. The contract has a ceiling value of $3,515.52 and an ultimate completion date of January 5, 2024. The contract covers the supply of KYLEENA 19.5 MG SYSTEMS, a contraceptive device, to fulfill the recurring medical supply needs of military health facilities worldwide. This award is part of DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $5,838.70, is for the delivery of KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,478.76 contract is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS, which is a contraceptive device. The contract has an ultimate completion date of April 29, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,062.08 order is for the delivery of KYLEENA 19.5 MG SYSTEMS, a contraceptive product, with a completion date of September 15, 2023. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999, awarded by DLA to DMS Pharmaceutical Group under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $6,196.90 contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
  • SPE2DB20D9329
    Indefinite Delivery Contract
  • SPE2DB20D9329-SPE2DB23FZK04
    Delivery Order

This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $7,031.04 contract is for the delivery of 4560094622 - KYLEENA 19.5 MG SYSTEMS, a contraceptive product, to support the medical supply needs of U.S. military health facilities worldwide.

DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical items. This contract, without any set-aside designation, is part of DMS Pharmaceutical Group's broader role as a prime vendor supporting the Department of Defense's (DoD) pharmaceutical supply chain. The company provides both routine and specialized medications, including branded, generic, and over-the-counter drugs, as well as medical supplies, to military healthcare facilities globally.

Generated 1/9/25, 9:23 AM